Cipla’s manufacturing facility at Pithampur, Indore receives “Official Action Indicated” classification from U.S. FDA for not meeting regulatory requirements; OAI status may delay/hold product pending approval

Pharmaceutical tablets and capsules are arranged on table in photo illustration

BENGALURU, Aug 5 (MeelBijendra) – Late on Saturday night, Indian drugmaker Cipla received an ‘Official Action Indicated’ (OAI) classification from the United States Food and Drug Administration’s (USFDA) inspection carried out in February 2023 at Cipla’s manufacturing facility in Pithampur, Indore. The United States Food and Drug Administration (USFDA), an agency of the United States … Read more

Cipla signs binding term sheet to sell its entire stake in Saba Investments; Deal worth US$6.50 million

Indian rupee notes

Indian multinational pharmaceutical company Cipla Limited announced the sale of its entire stake in Saba Investments Limited on 15 May 2023. Saba Investments Limited is a UAE-based Joint Venture between Cipla Limited and Shibam Group Holding Limited. Read Also: Tech Mahindra Ltd approves proposal to increase stake in Tech Mahindra Arabia Ltd to 80% by … Read more

Cipla promoters sell 2.5% stake, promoter group now holds 34.23% stake: Cipla stock down 3.5%

Cipla promoters sell 2.5% stake, promoter group now holds 34.23% stake: Cipla stock down 3.5%

Today the share price of India’s leading pharma company Cipla Limited fell almost 3.5%. Cipla promoters Yusuf Hamied and Mustafa Hamied sold their 2.5% stake through a block deal. Cipla told the exchanges that the promoters of the company, which is still in its eighties, are selling their stake due to personal and philanthropy reasons. … Read more